Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Protecting the body from free radicals to support healthy cellular function and balance*
If GLP-1 receptor agonists do influence rheumatoid arthritis, the mechanisms would likely involve both direct immunomodulatory effects and indirect benefits through metabolic improvement
Sold as a research reagent only
Upfront efforts to define the safety and impurity profile of the small molecule streamlines later scale-up, technology transfer and regulatory review
Importantly, highlighting the increasing popularity of the drugs, 19.5% of participants indicated that while they have not yet used a GLP-1 medication, they are considering using one in the next year
(PubMed) Nantz MP, Rowe CA, Muller CE, Creasy RA, Stanilka JM, Percival SS
